HMGB1 and Sepsis: Lidocaine has also been shown in vivo (in animal models of sepsis and sterile inflammation) to inhibit expression of the inflammatory mediator high mobility group box 1 (HMGB1), which in turn suppresses activation of NF-κB (102, 103).